| [1] | World Health Organization. World malaria report 2024: addressing inequity in the global malaria response[R]. Geneva: WHO, 2024: 6-9. | | [2] | Luzolo AL, Ngoyi DM. Cerebral malaria[J]. Brain Res Bull, 2019, 145: 53-58. | | [3] | Birbeck GL, Molyneux ME, Kaplan PW, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study[J]. Lancet Neurol, 2010, 9(12): 1173-1181. | | [4] | Duffy PE. Current approaches to malaria vaccines[J]. Curr Opin Microbiol, 2022, 70: 102227. | | [5] | Stanisic DI, Good MF. Malaria vaccines: progress to date[J]. BioDrugs, 2023, 37(6): 737-756. | | [6] | Feng GQ, Kurtovic L, Agius PA, et al. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children[J]. BMC Med, 2022, 20(1): 289. | | [7] | Chen JG, Liu SC, Nie Q, et al. Exosome-derived long noncoding RNAs: mediators of host-Plasmodium parasite communication[J]. Wiley Interdiscip Rev RNA, 2023: e1808. | | [8] | Chen JG, Du YT, Guan CH, et al. Extracellular vesicles derived from Plasmodium-infected hosts as stimuli of “trained” innate immunity[J]. CMC, 2023, 30(39): 4450-4465. | | [9] | Lv YY, Wu S, Nie Q, et al. Extracellular vesicles derived from Plasmodium-infected red blood cells alleviate cerebral malaria in Plasmodium berghei ANKA-infected C57BL/6J mice[J]. Int Immunopharmacol, 2024, 132: 111982. | | [10] | Rehman FU, Liu Y, Zheng M, et al. Exosomes based strategies for brain drug delivery[J]. Biomaterials, 2023, 293: 121949. | | [11] | Picca A, Guerra F, Calvani R, et al. Circulating extracellular vesicles: friends and foes in neurodegeneration[J]. Neural Regen Res, 2022, 17(3): 534-542. | | [12] | Long XB, Yao XL, Jiang Q, et al. Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury[J]. J Neuroinflammation, 2020, 17(1): 89. | | [13] | Elieh-Ali-Komi D, Shafaghat F, Alipoor SD, et al. Immunomodulatory significance of mast cell exosomes (MC-EXOs) in immune response coordination[J]. Clin Rev Allergy Immunol, 2025, 68(1): 20. | | [14] | Martin-Jaular L, Nakayasu ES, Ferrer M, et al. Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections[J]. PLoS One, 2011, 6(10): e26588. | | [15] | Rangel-Ramírez VV, González-Sánchez HM, Lucio-García C. Exosomes: from biology to immunotherapy in infectious diseases[J]. Infect Dis (Lond), 2023, 55(2): 79-107. | | [16] | Ghazanfari N, Mueller SN, Heath WR. Cerebral malaria in mouse and man[J]. Front Immunol, 2018, 9: 2016. | | [17] | Bashyal S, Thapa C, Lee S. Recent progresses in exosome-based systems for targeted drug delivery to the brain[J]. J Control Release, 2022, 348: 723-744. 704-713 | | [18] | Eichenberger RM, Sotillo J, Loukas A. Immunobiology of para sitic worm extracellular vesicles[J]. Immunol Cell Biol, 2018: 704-713. | | [19] | Alloo J, Leleu I, Grangette C, et al. Parasite infections, neuroinflammation, and potential contributions of gut microbiota[J]. Front Immunol, 2022, 13: 1024998. | | [20] | Pais TF, Ali H, Moreira da Silva J, et al. Brain endothelial STING1 activation by Plasmodium-sequestered heme promotes cerebral malaria via type I IFN response[J]. Proc Natl Acad Sci U S A, 2022, 119(36): e2206327119. | | [21] | Ramachandran A, Sharma A. Dissecting the mechanisms of pathogenesis in cerebral malaria[J]. PLoS Pathog, 2022, 18(11): e1010919. | | [22] | Willimann K, Matile H, Weiss NA, et al. In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria[J]. J Exp Med, 1995, 182(3): 643-653. | | [23] | Yipp BG, Anand S, Schollaardt T, et al. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow[J]. Blood, 2000, 96(6): 2292-2298. | | [24] | Nagamine Y, Hayano M, Kashiwamura SI, et al. Involvement of interleukin-18 in severe Plasmodium falciparum malaria[J]. Trans R Soc Trop Med Hyg, 2003, 97(2): 236-241. | | [25] | Xu Lou I, Zhou HF, Wan HT. The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: mechanisms and therapeutic perspectives[J]. Front Immunol, 2025, 16: 1656422. | | [26] | Wu S, Nie Q, Tan S, et al. The immunity modulation of transforming growth factor-β in malaria and other pathological process[J]. Int Immunopharmacol, 2023, 122: 110658. | | [27] | Islam R, Vrionis F, Hanafy KA. Microglial TLR4 is critical for neuronal injury and cognitive dysfunction in subarachnoid hemorrhage[J]. Neurocrit Care, 2022, 37(3): 761-769. | | [28] | Hu ZQ, Ma RJ, Sun JQ, et al. Tenascin-C facilitates microglial polarization via TLR4/MyD88/NF-κB pathway following subarachnoid hemorrhage[J]. J Inflamm Res, 2025, 18: 3555-3570. | | [29] | Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB[J]. Infect Immun, 2006, 74(6): 3262-3270. | | [30] | Zhang J, Li Q, Zou YR, et al. HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils[J]. Int Immunopharmacol, 2021, 94: 107433. |
|